Global Medical REIT Inc. (GMRE)
NYSE: GMRE · Real-Time Price · USD
6.79
+0.06 (0.89%)
Aug 13, 2025, 4:00 PM - Market closed
Global Medical REIT Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Global Medical REIT stock ranges from a low of $9.00 to a high of $11.75. The average analyst price target of $10.38 forecasts a 52.87% increase in the stock price over the next year.
Price Target: $10.38 (+52.87%)
Analyst Consensus: Buy
* Price targets were last updated on May 8, 2025.
Analyst Ratings
The average analyst rating for Global Medical REIT stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +32.55% | May 8, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 12, 2025 |
| Berenberg | Berenberg | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +73.05% | Oct 18, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +47.28% | May 13, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +62.00% | May 8, 2023 |
Financial Forecast
Revenue This Year
144.96M
from 138.76M
Increased by 4.47%
Revenue Next Year
150.18M
from 144.96M
Increased by 3.60%
EPS This Year
0.12
from 0.01
Increased by 862.03%
EPS Next Year
0.15
from 0.12
Increased by 25.00%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 151.8M | 163.2M | 159.6M | |
| Avg | 145.0M | 150.2M | 152.8M | |
| Low | 136.9M | 141.6M | 144.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 9.4% | 12.6% | 6.3% | |
| Avg | 4.5% | 3.6% | 1.7% | |
| Low | -1.4% | -2.4% | -3.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.30 | 0.41 | 0.11 |
| Avg | 0.12 | 0.15 | 0.09 |
| Low | 0.06 | 0.05 | 0.08 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2,375.8% | 246.1% | -29.0% |
| Avg | 862.0% | 25.0% | -37.9% |
| Low | 378.1% | -58.6% | -47.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.